Washington's AI safety pivot signals push for guardrails and oversight

The White House is weighing executive actions to regulate the most powerful AI models and establish an oversight process similar to FDA approvals, including possible licensing for government use and deployment/testing rules, as Washington seeks to balance innovation with security amid private-sector collaboration and a potential China summit—but no concrete steps have been announced yet.